Navigation Links
FDA Restricts Access to Avandia
Date:9/24/2010

By Steven Reinberg
HealthDay Reporter

THURSDAY, Sept. 23 (HealthDay News) -- In response to major concerns about heart risks, U.S. health officials on Thursday severely restricted use of the diabetes drug rosiglitazone (Avandia) to patients with type 2 diabetes who cannot control their disease on other medications.

U.S. Food and Drug Administration officials also ordered the drug's manufacturer, GlaxoSmithKline, to get an independent review of a key company-run trial of the drug's heart effects. And they pulled the plug on another company-run trial comparing Avandia to its competitor, pioglitazone (Actos).

"Because of concerns about cardiovascular safety, FDA is announcing regulatory action on medications containing rosiglitazone," FDA Commissioner Dr. Margaret A. Hamburg said during a morning press conference. "FDA is significantly restricting the use of these products by requiring the manufacturer to submit a Risk Evaluation and Mitigation Strategy [REMS]."

The FDA is requiring GlaxoSmithKline to develop a program that will restrict access to the drug to those patients for whom other treatments have not worked.

In addition, doctors will have to state and document a patient's eligibility to use Avandia. They will also have to tell patients about the cardiovascular safety risks associated with Avandia, and patients will have to acknowledge that they understand those risks.

Those currently using Avandia will be allowed to continue taking the drug, Hamburg said. However, once the REMS is in place these patients will also have to have their doctors justify use of the drug.

FDA officials believe this program will significantly reduce the number of people taking Avandia.

According to the agency, there was not enough evidence of Avandia's cardiovascular risks to pull the drug from the market, which is why it opted to restrict its use instead.

But in Europe, the European Medicines Agency h
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Psychologists Say New Jerseys Largest Health Plan Violates Patient Privacy, Restricts Access to Care and Wastes Taxpayer Money
2. Drug that restricts blood supply to prostate tumors delays disease progression
3. New Rural RHIO Aims to Achieve Meaningful Use With Prognosis ChartAccess Comprehensive EMR
4. American Heart Association Rapid Access Journal Report: Study Finds Racial Gaps Continue in Heart Disease Awareness, Low Knowledge of Heart Attack Warning Signs Among Women
5. Bluegiga Expands to Health and Medical Market With the New Bluegiga eHealth Access Point
6. Trade Privacy LLC: Research Concludes Apple Inc. Has Blocked Their Import Records from Public Access
7. Inadequate access to opioid-based pain relief is a human rights issue for cancer patients
8. Survey Finds Access to Mammograms Declining for Women Under Age 50
9. The American Association on Health and Disability (AAHD) and the Susan G. Komen for the Cure Partner to Increase Accessibility for Women with Disabilities at Mammogram Facilities in the DC Metro Area
10. Pew Report Finds Majority of States Fail to Ensure Proper Dental Health & Access to Care for Children
11. Access to Mammograms Drops After Guidelines Change
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Restricts Access to Avandia
(Date:7/31/2014)... NV (PRWEB) July 31, 2014 Weblify has ... after 4 years of development and testing. The result ... monetized websites in as little as 5 minutes without knowing ... full Weblify review , Shane Michaels, an SEO expert, agrees ... quickly. “I’ve seen a lot of web site builders ...
(Date:7/31/2014)... Angeles, CA (PRWEB) July 31, 2014 ... Southern California’s best Plastic Surgeons to consumers considering cosmetic ... recommended by their peers whose goal is to educate ... The doctors are selected through a validated referral system ... who are the best in their respective fields. ...
(Date:7/31/2014)... July 31, 2014 Daily Gossip indicates ... pain killers for this health problem. However, this is ... new program was created by Peter Bansby, who decided ... sufferers from all over the world find a unique ... people wish to view pros and cons from a ...
(Date:7/31/2014)... 31, 2014 Current residents at ... program in Flagstaff, AZ, learn to kayak safely for ... and paddle strokes in preparation for next week's wilderness ... think that [the kayaking course] teaches [residents] to listen ... with in their early part of their sobriety," said ...
(Date:7/31/2014)... CarePoint Health is proud to ... has joined our network, CarePoint Health Medical Group. ... Hundreds of highly skilled and experienced physicians comprise ... top doctors and practices in Hudson County, representing ... represents CarePoint Health’s commitment to provide the highest ...
Breaking Medicine News(10 mins):Health News:Weblify Review Exposes Ricky Mataka And His New Site Building Platform 2Health News:Weblify Review Exposes Ricky Mataka And His New Site Building Platform 3Health News:The New Doctors’ Directory, Cosmetic Town Does the Research for Consumers of Plastic Surgeries 2Health News:Neuropathy Miracle Review Reveals Peter Bansby's Unique Cure Method 2Health News:Back2Basics Substance Abuse Residents Take Kayaking Class for the First Time 2Health News:Dr. Rizvi Joins CarePoint Health Medical Group 2
... flagship event, the Molecular Medicine Tri-Conference (February 24-27, 2009) ... Plenary Keynotes. , ... ... Healthtech Institute’s (CHI) flagship event, the Molecular Medicine Tri-Conference ...
... HIV/AIDS , , WASHINGTON, Nov. 21 ... women ages 25-34 today. HIV infections could be reduced by ... their infection and adopted behavioral changes to limit the spread of ... AIDS Living Quilt ( www.livingquilt.org ) was featured this week at ...
... $50 million “YES Medical Technology Fund”, a private ... with revenues and profits to expand their commercialization ... provide growth capital to medtech companies that have ... (minimum $2 million EBITDA), and have the potential ...
... genetically distinct from other known species , , FRIDAY, Nov. 21 ... virus has been identified by American and Ugandan scientists. ... an outbreak in western Uganda in 2007. It is genetically ... more than 30 percent at the genetic level, said the ...
... Inc. (OTC Bulletin Board: HFGB), a leading developer and ... in pharmaceutical,nutraceutical and food production, is pleased to announce ... periods ended September 30, 2008. , ... in the third quarter of 2008, Huifeng has,managed to ...
... Velocity(TM) 6 offers advanced technology and lower entry-level price point , ... Sonic Innovations, Inc. (Nasdaq: SNCI ) the ... a new product to its recently launched Velocity series. The ... also includes Velocity 24, 12 and 4. , ...
Cached Medicine News:Health News:Four of Molecular Medicine's Thought Leaders will Keynote at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference 2Health News:Four of Molecular Medicine's Thought Leaders will Keynote at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference 3Health News:Four of Molecular Medicine's Thought Leaders will Keynote at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference 4Health News:Southern AIDS Living Quilt Raises Awareness at National HIV Summit 2Health News: Yankee Equity Solution ("YES") Launches $50 Million Fund for Mass.-Based Medtech Companies 2Health News:Huifeng Bio-Pharmaceutical (HFGB) Reports Record Sales and Net Income 2Health News:Sonic Innovations Launches New Product to Meet Growing Consumer Need and Demand for Digital Hearing Aids 2Health News:Sonic Innovations Launches New Product to Meet Growing Consumer Need and Demand for Digital Hearing Aids 3
(Date:7/31/2014)... and LONDON , July 31, 2014 ... provider for the medical industries, announced today the incorporation of genae ... United Kingdom has one of the largest medical ... billion in 2012 and it is projected to increase by a ... 234 billion in 2012, equal to 9.5% of GDP. Despite recessionary ...
(Date:7/31/2014)... NEW YORK , July 31, 2014 /PRNewswire-USNewswire/ ... of discovering and developing better, faster and affordable ... as Senior Vice President, External Affairs. Mr. ... served as Head of Major Donor Relations for ... Fund). In his role, Mr. Brock will guide ...
(Date:7/31/2014)... 2014  Genomic Health, Inc. (Nasdaq: GHDX ) ... and webcast on Thursday, August 7 at 4:30 p.m. Eastern ... call and webcast will follow the release of the second ... Details To access the live conference call on August 7 ... 303-7208 from the United States and ...
Breaking Medicine Technology:genae Opens Offices in London 2TB Alliance Appoints Willo Brock Senior Vice President, External Affairs 2Genomic Health to Announce Second Quarter 2014 Financial Results and Host Conference Call on Thursday, August 7, 2014 2Genomic Health to Announce Second Quarter 2014 Financial Results and Host Conference Call on Thursday, August 7, 2014 3Genomic Health to Announce Second Quarter 2014 Financial Results and Host Conference Call on Thursday, August 7, 2014 4
... Inc. (NASDAQ: IDIX ), a biopharmaceutical company ... the treatment of human viral diseases, today announced that ... and Lead Director of Idenix,s Board and former President ... as Chairman of the Board. Additionally, Idenix has appointed ...
... Inc. (NASDAQ: AVNR ) today announced that company management ... & Company Healthcare Conference , Location: Boston Marriott, Boston , MA ... a.m. ET , 2012 Roth OC Growth ... Date: Tuesday March 13, 2012 , Presentation time: 4:30 p.m. PT ...
Cached Medicine Technology:Idenix Pharmaceuticals Elects Thomas Hodgson as Chairman of the Board and Appoints Michael Wyzga to Its Board of Directors 2
Optoelectronic stimulator, "ganzfeld" stimulations for flash VEP, flash ERG and sensory EOG. Pattern stimulations for ERG and VEP, multifocal stimulations for ERG and VEP, complies with international...
5 mm...
1.0 mm diameter head, 0.75 mm deep bite....
Optec vision tester....
Medicine Products: